Sysmex Transfusion Webinar Series 4: Initiation & Governance of Haemovigilance in New Zealand
Speaker
Dr Richard Charlewood
Transfusion Medicine Specialist
New Zealand Society of Blood Transfusion
Auckland, New Zealand
Dr Richard Charlewood trained in South Africa and the United Kingdom as a haematologist. He has also studied computer science in South Africa. Since 2003, he has worked as a Transfusion Medicine Specialist at the New Zealand Blood Service, based in Auckland. He has served on the councils of the South African Society of Haematology, the Australian and New Zealand Society for Blood Transfusion and the Biotherapeutics Association of Australasia.
Moderator
Professor Ponlapat Rojnuckarin
Division of Haematology, Department of Medicine,
Chulalongkorn University
Bangkok, Thailand
Professor Ponlapat Rojnuckarin earned the MD degree from Chulalongkorn University and the PhD degree (Biochemistry) from University of Washington, USA. He is currently the President-elected of the Thai Society of Hematology, Head of the Center for Medical Diagnostic Laboratories (CMDL), Faculty of Medicine, Chulalongkorn University and Chair of the Haematology Training and Examination Subcommittee, The Royal College of Physicians of Thailand.
Abstract of Lecture:
Haemovigilance, according to the Council of Europe definition, states: “The organised surveillance procedures related to serious or unexpected events or reactions in donors or recipients and the epidemiological follow up of donors”.
New Zealand’s haemovigilance programme has been running continuously since 2007, covering transfusion activity of the entire country. The haemovigilance programme is vein-to-vein by design, covering everything from donor adverse events, through to adverse reactions to blood components and fractionated blood products.
In this talk we will look at why the programme was established, how it was set up, and its governance. We also look at its output and relevance fourteen years on, including areas that have worked well and those that have not.
A comparison with the haemovigilance programmes of other countries will show the differences in their programmes, together with some of the reasons why the programmes have evolved the way they have.
This talk will be given by Transfusion Medicine Specialist from New Zealand Blood Services, Dr Richard Charlewood and chaired by the President of Thai Haematology Society, Professor Ponlapat Rojnuckarin of King Chulalongkon University, Thailand.
[wp-video-popup video=”https://youtu.be/rabYNArP8J4″]
We hoped you have enjoyed the webinar and gained new insights!
May we request your time for a short survey?